Log in or Sign up for Free to view tailored content for your specialty!
Infectious Diseases News
Asymptomatic, mild COVID-19 at frozen embryo transfer does not worsen pregnancy outcomes
Women with asymptomatic or mild COVID-19 infection at the time of frozen embryo transfer did not experience significant adverse early pregnancy outcomes, researchers reported in BMC Pregnancy and Childbirth.
Analysis shows alert systems are ‘valuable tools’ to reduce sepsis-related death
Adults treated in EDs with established sepsis alert systems benefited from reduced mortality risk and length of hospitalization compared with facilities with no alert system, according to data published in JAMA Network Open.
Log in or Sign up for Free to view tailored content for your specialty!
Daily doxycycline shows promise against STIs in small studies
In June, the CDC began recommending doxycycline post-exposure prophylaxis — or doxy-PEP, as it is commonly known — as a prevention strategy for STIs in certain high-risk populations.
Top in ID: Breakthrough in HIV prevention; rapid test detects malaria-spreading mosquitoes
Researchers found that lenacapavir, an investigational long-acting antiretroviral drug, prevented 100% of new HIV infections among cisgender women in Africa who received injections every 26 weeks.
Q&A: CDC issues warning amid surge in dengue virus
In March, Puerto Rico declared a public health emergency after recording 549 cases of dengue virus since the start of 2024. The number rose to more than 1,900 cases as of July 24, when the CDC issued a health alert for the United States.
Study supports testing HIV PrEP users for STIs at 6 months instead of 3
Testing HIV PrEP users for STIs every 6 months did not increase the risk for STIs compared with testing them every 3 months and could reduce the cost of PrEP programs, according to a study.
Three-quarters of people with HIV globally are on ART, UNAIDS reports
Three-quarters of people globally living with HIV are on ART, a roughly 30% increase during the last nine years, and fewer people acquired HIV in 2023 than at any point since the late 1980s, UNAIDS reported.
Self-management program ‘offers an important blueprint’ for treatment of chronic pain
A self-management program tailored to individuals with HIV significantly reduced the impact and severity of chronic pain, according to results from a randomized study published in JAMA Internal Medicine.
Full results confirm potential breakthrough in HIV prevention
In June, Gilead Sciences announced that its investigational antiretroviral drug lenacapavir prevented 100% of new HIV infections during a phase 3 trial conducted among cisgender women in Africa.
Study: Funding pullbacks threaten progress on UN goal to end HIV/AIDS
Despite global progress toward eliminating HIV — including a growing number of nations that have hit goals to diagnose and successfully treat patients — funding pullbacks threaten to add decades to the battle, according to a study.